Veterinary Medicines

MILBETAB 2,5 MG/25 MG TABLETS FOR SMALL DOGS AND PUPPIES

Authorised
  • Milbemycin oxime
  • Praziquantel
Download as PDF

Product identification

Medicine name:
MILBETAB 2,5 MG/25 MG TABLETS FOR SMALL DOGS AND PUPPIES
Milbetab 2,5 mg/25 mg tabletten voor kleine honden en puppy’s
Active substance:
  • Milbemycin oxime
  • Praziquantel
Target species:
  • Dog
Route of administration:
  • Oral use

Product details

Active substance and strength:
  • Milbemycin oxime
    2.50
    milligram(s)
    /
    1.00
    Tablet
  • Praziquantel
    25.00
    milligram(s)
    /
    1.00
    Tablet
Pharmaceutical form:
  • Tablet
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QP54AB51
Legal status of supply:
  • Veterinary medicinal product not subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Netherlands
Package description:
  • Cardboard box containing 30 tablets. (3 blisters strips of 10)
  • Cardboard box containing 30 tablets. (15 blisters strips of 2)
  • Cardboard box containing 32 tablets. (8 blisters strips of 4)
  • Cardboard box containing 32 tablets. (4 blisters strips of 8)
  • Cardboard box containing 40 tablets. (10 blisters strips of 4)
  • Cardboard box containing 40 tablets. (5 blisters strips of 8)
  • Cardboard box containing 40 tablets. (4 blisters strips of 10)
  • Cardboard box containing 48 tablets. (24 blisters strips of 2)
  • Cardboard box containing 48 tablets. (12 blisters strips of 4)
  • Cardboard box containing 48 tablets. (6 blisters strips of 8)
  • Cardboard box containing 50 tablets. (5 blister strips of 10)
  • Cardboard box containing 96 tablets. (12 blister strips of 8)
  • Cardboard box containing 100 tablets. (10 blister strips of 10)
  • Cardboard box containing 2 tablets. (1 blister strip of 2)
  • Cardboard box containing 4 tablets. (2 blisters strips of 2)
  • Cardboard box containing 4 tablets. (1 blister strip of 4)
  • Cardboard box containing 8 tablets. (4 blisters strips of 2)
  • Cardboard box containing 8 tablets. (2 blisters strips of 4)
  • Cardboard box containing 10 tablets. (5 blisters strips of 2)
  • Cardboard box containing 10 tablets. (1 blister strips of 10)
  • Cardboard box containing 16 tablets. (4 blisters strips of 4)
  • Cardboard box containing 16 tablets. (2 blisters strips of 8)
  • Cardboard box containing 20 tablets. (10 blisters strips of 2)
  • Cardboard box containing 20 tablets. (5 blisters strips of 4)
  • Cardboard box containing 20 tablets. (2 blisters strips of 10)
  • Cardboard box containing 24 tablets. (6 blisters strips of 4)
  • Cardboard box containing 24 tablets. (3 blisters strips of 8)

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Generic application (Article 18 of Regulation (EU) 2019/6)
Marketing authorisation holder:
  • Chanelle Pharmaceuticals Manufacturing Limited
Marketing authorisation date:
Manufacturing sites for batch release:
  • Chanelle Pharmaceuticals Manufacturing Limited
Responsible authority:
  • Medicines Evaluation Board
Authorisation number:
  • REG NL 132926
Date of authorisation status change:
Reference member state:
  • France
Procedure number:
  • FR/V/0494/001
Concerned member states:
  • Austria
  • Belgium
  • Bulgaria
  • Croatia
  • Cyprus
  • Czechia
  • Denmark
  • Estonia
  • Finland
  • Germany
  • Greece
  • Hungary
  • Ireland
  • Italy
  • Latvia
  • Lithuania
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Romania
  • Slovakia
  • Spain
  • Sweden
Generic of:

Documents

Combined File of all Documents

This document does not exist in this language (English). You can find it in another language below.
Dutch (PDF)
Published on: 29/12/2025
Download